These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 39206915)

  • 1. Epigenetic Modulations in Breast Cancer: An Emerging Paradigm in Therapeutic Implications.
    Sarkar S; Venkatesh D; Kandasamy T; Ghosh SS
    Front Biosci (Landmark Ed); 2024 Aug; 29(8):287. PubMed ID: 39206915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
    Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
    Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
    Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
    Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.
    Walsh L; Gallagher WM; O'Connor DP; Ní Chonghaile T
    Expert Rev Mol Diagn; 2016; 16(5):541-51. PubMed ID: 26895288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA.
    Szczepanek J; Skorupa M; Jarkiewicz-Tretyn J; Cybulski C; Tretyn A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals.
    Shukla S; Penta D; Mondal P; Meeran SM
    Adv Exp Med Biol; 2019; 1152():293-310. PubMed ID: 31456191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenomics and breast cancer.
    Lo PK; Sukumar S
    Pharmacogenomics; 2008 Dec; 9(12):1879-902. PubMed ID: 19072646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.
    Lu Y; Chan YT; Tan HY; Li S; Wang N; Feng Y
    Mol Cancer; 2020 Apr; 19(1):79. PubMed ID: 32340605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics as a therapeutic target in breast cancer.
    Connolly R; Stearns V
    J Mammary Gland Biol Neoplasia; 2012 Dec; 17(3-4):191-204. PubMed ID: 22836913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of epigenetic mechanisms in epithelial-to-mesenchymal transition of breast cancer cells.
    Nickel A; Stadler SC
    Transl Res; 2015 Jan; 165(1):126-42. PubMed ID: 24768944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies.
    Trnkova L; Buocikova V; Mego M; Cumova A; Burikova M; Bohac M; Miklikova S; Cihova M; Smolkova B
    Biomed Pharmacother; 2024 May; 174():116559. PubMed ID: 38603889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic targeting in breast cancer: therapeutic impact and future direction.
    Lustberg MB; Ramaswamy B
    Drug News Perspect; 2009 Sep; 22(7):369-81. PubMed ID: 19890494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer.
    Pradhan N; Parbin S; Kar S; Das L; Kirtana R; Suma Seshadri G; Sengupta D; Deb M; Kausar C; Patra SK
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1651-1665. PubMed ID: 30954555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
    Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
    Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    M JR; S V
    Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer epigenetics: current and evolving treatment.
    Purja S; Nguyen DT; Kim E
    Breast Cancer; 2024 Sep; 31(5):869-885. PubMed ID: 38861041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
    Oh S; Ko JY; Oh C; Yoo KH
    Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Modulators as Therapeutic Agents in Cancer.
    Patnaik E; Madu C; Lu Y
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic therapy for breast cancer.
    Cai FF; Kohler C; Zhang B; Wang MH; Chen WJ; Zhong XY
    Int J Mol Sci; 2011; 12(7):4465-87. PubMed ID: 21845090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.
    Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G
    Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.